v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net (loss) income $ (34,383) $ 33,387
Adjustments to reconcile net (loss) income to net cash flows provided by operating activities    
Deferred income taxes (9,623) 6,659
Credit loss expense 7,572 3,149
Depreciation and amortization 4,611 11,661
Share-based compensation 2,419 13,933
Non-cash lease expenses 1,002 937
Other 246 543
Increase (decrease) in cash resulting from changes in:    
Accounts receivable 29,425 (25,507)
Inventory 3,251 (2,695)
Other assets 3,735 (4,931)
Accounts payable 2,300 3,705
Accrued compensation (14,367) 5,571
Accrued expenses 1,385 3,812
Other liabilities (1,790) (1,177)
Net cash flows (used in) provided by operating activities (4,217) 49,047
Cash flows from investing activities:    
Cash paid for acquisitions (5,000) (3,764)
Purchases of equipment (1,334) (748)
Patent application costs (136) (39)
Other investments 0 (2,000)
Net cash flows used in investing activities (6,470) (6,551)
Cash flows from financing activities:    
Principal payments on Citizens Term Loan Facility (18,000) (750)
Cash paid for share repurchases pursuant to Share Repurchase Plan (12,772) 0
Stock repurchased for tax withholdings on vesting of restricted stock (2,096) (3,067)
Cash paid for Profit Share Payment (Note 12) (1,631) (1,012)
Deferred financing costs (144) 0
Net cash flows used in financing activities (34,643) (4,829)
Net change in cash (45,330) 37,667
Cash and cash equivalents, beginning of period 166,121 104,416
Cash and cash equivalents, end of period $ 120,791 $ 142,083